Drug record
What four public record sets show for omeprazole. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.030 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $370.0 million | Details |
| FDA recall records | 17 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Omeprazole Dr 20 Mg Capsule: pharmacies pay about $0.030 each, or $0.914 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| OMEPRAZOLE DR 10 MG CAPSULE | Generic | $0.073 per each | $2.19 | Oct 21, 2026 |
| OMEPRAZOLE DR 20 MG CAPSULE | Generic | $0.030 per each | $0.914 | Oct 21, 2026 |
| OMEPRAZOLE DR 20 MG ODT OTC | Generic | $0.475 per each | $14.26 | Oct 21, 2026 |
| OMEPRAZOLE DR 20 MG TABLET OTC | Generic | $0.391 per each | $11.74 | Oct 21, 2026 |
| OMEPRAZOLE DR 40 MG CAPSULE | Generic | $0.050 per each | $1.49 | Oct 21, 2026 |
| OMEPRAZOLE MAG DR 20 MG CAP OTC | Generic | $0.389 per each | $11.67 | Oct 21, 2026 |
| OMEPRAZOLE MAG DR 20 MG TABLET OTC | Generic | $0.474 per each | $14.23 | Oct 21, 2026 |
| OMEPRAZOLE MAG DR 20.6 MG CAP OTC | Generic | $0.389 per each | $11.67 | Oct 21, 2026 |
| PRILOSEC DR 10 MG SUSPENSION | Brand | $14.79 per each | $443.56 | Oct 21, 2026 |
| PRILOSEC DR 2.5 MG SUSPENSION | Brand | $14.75 per each | $442.44 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $370.0 million for the 2 products below. That is down 7% from $399.3 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Omeprazole Omeprazole | $366.7 million | 7,509,766 | $12.70 | $48.83 | $396.3 million |
| Prilosec Omeprazole Magnesium | $3.2 million | 823 | $993.36 | $3,927.56 | $3.0 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Konvomep, Omeprazole-Sodium Bicarbonate, Talicia, Zegerid.
Recalls reported to the FDA that name this drug.
The FDA has 17 recall records that name omeprazole in the product description (15 Class II · 2 Class III). 2 are still marked ongoing.
Omeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Manufactured for: Qualient Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, NDC 82009-022-10. NDC 82009-022-10
Reason: Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 0880
Reason: Subpotent Drug: Out of specification for assay
GOOD SENSE OMEPRAZOLE TABLET 14CT SKU 900055 PRILOSEC OTC TABLET 14 CT SKU914128 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
Reason: CGMP Deviations: product held outside appropriate storage temperature conditions.
Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium), 24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1
Reason: CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
Prilosec (Omeprazole Magnesium) For Delayed-Release Oral Suspension 10 mg Rx only NDC 70515-610-01 Mfd. for: Covis Pharma, Zug, 6300 Switzerland
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Omeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated, Camarillo, CA 93012-8601 USA, NDC 51407-129-10
Reason: Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer
Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10
Reason: Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.
Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN 38485, NDC 00000-0001-07
Reason: Lack of Processing Controls.
FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 3 OZ, Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-03
Reason: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-05
Reason: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Omeprazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Omeprazole Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for omeprazole. This page is public-record information, not medical advice.